摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

N-(5,5-dimethyl-3-oxocyclohex-1-en-1-yl)benzamide | 23674-57-9

中文名称
——
中文别名
——
英文名称
N-(5,5-dimethyl-3-oxocyclohex-1-en-1-yl)benzamide
英文别名
Benzamide, N-(5,5-dimethyl-3-oxo-1-cyclohexen-1-yl)-;N-(5,5-dimethyl-3-oxocyclohexen-1-yl)benzamide
N-(5,5-dimethyl-3-oxocyclohex-1-en-1-yl)benzamide化学式
CAS
23674-57-9
化学式
C15H17NO2
mdl
——
分子量
243.305
InChiKey
XAXJAVCKMWVKNB-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 熔点:
    144-146 °C
  • 沸点:
    422.6±45.0 °C(Predicted)
  • 密度:
    1.13±0.1 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    2.3
  • 重原子数:
    18
  • 可旋转键数:
    2
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.33
  • 拓扑面积:
    46.2
  • 氢给体数:
    1
  • 氢受体数:
    2

SDS

SDS:45af06f7e200ea448ce914040eddbc17
查看

反应信息

  • 作为产物:
    参考文献:
    名称:
    Kava analogues as agents for treatment of periodontal diseases: Synthesis and initial biological evaluation
    摘要:
    Six kava analogues of the structural type 3-oxocyclohex-1-en-1-yl benzoates (and corresponding benzamides) were synthesized and evaluated for their affect on periodontal deconstruction in collagen anti-body primed oral gavage model of periodontitis. The compounds were prepared through an acylation or amidation of the enolizable cyclic 1,3-diketone. We have learned that three of the analogues are responsible for the reduction of inflammatory cell counts within soft tissue. These novel kava-like molecules where the lactone is replaced by an alpha,beta-unsaturated ketone show promise in the prevention and treatment of inflammation and alveolar bone loss associated with periodontitis.
    DOI:
    10.1016/j.bmcl.2018.05.026
点击查看最新优质反应信息

文献信息

  • Enaminones 9. Further studies on the anticonvulsant activity and potential type IV phosphodiesterase inhibitory activity of substituted vinylic benzamides
    作者:Alan J. Anderson、Jesse M. Nicholson、Oladapo Bakare、Ray J. Butcher、Tiffany L. Wilson、K.R. Scott
    DOI:10.1016/j.bmc.2005.09.023
    日期:2006.2
    Structure-activity relationship studies were employed to synthesize a series of 3- and 3,4-substituted benzamides from 3-amino-2-cyclohexenones. An improved method for the synthesis of benzamides from 3-amino-2-cyclohexenones is presented which provided significantly higher yields (71-79%) for the reported compounds. NMR and X-ray structural analyses were undertaken to note the possible intra- and intermolecular
    结构-活性关系研究用于从3-氨基-2-环己烯酮合成一系列3-和3,4-取代的苯甲酰胺。提出了一种从3-氨基-2-环己烯酮合成苯甲酰胺的改进方法,该方法为所报道的化合物提供了明显更高的收率(71-79%)。进行了NMR和X射线结构分析,以发现合成类似物可能的分子内和分子间相互作用。分子模型研究被用来确定最小化的构型,并与它们的X射线结构进行了相关性比较。这些新实体被评估为潜在的抗惊厥药和IV型磷酸二酯酶抑制剂(PDE4)。
  • Synthesis, characterization and anticonvulsant activity of enaminones. Part 6: Synthesis of substituted vinylic benzamides as potential anticonvulsants
    作者:James E. Foster、Jesse M. Nicholson、Raymond Butcher、James P. Stables、Ivan O. Edafiogho、Angela M. Goodwin、Michael C. Henson、Carlynn A. Smith、K.R. Scott
    DOI:10.1016/s0968-0896(99)00185-6
    日期:1999.11
    A comparison of enaminones from various unsubstituted and p-substituted benzamides to the analogous benzylamines has been undertaken with the aim of elucidating the essential structural parameters necessary for anticonvulsant activity. Initial studies on methyl 4-N-(benzylamino)-6-methyl-2-oxocyclohex-3-en-1-oate, 3a, 3-N-(benzylamino)cyclohex-2-en-1-one, 3p, and 5,5-dimethyl-3-N-(benzylamino)-cyclohex-2-en-1-one
    为了阐明抗惊厥活性所必需的基本结构参数,已经进行了将各种未取代和对位取代的苯甲酰胺中的烯胺酮与类似的苄胺进行比较。对4-N-(苄氨基)-6-甲基-2-氧代环己-3-烯-1-酸酯,3a,3-N-(苄基氨基)环己-2-烯-1-酮,3p和5,5-二甲基-3-N-(苄氨基)-环己-2-烯-1-酮,3r表示苄胺具有明显的最大抗电击癫痫发作(MES)活性。对类似苯甲酰胺的评估表明,其抗惊厥活性存在显着差异,这些差异很可能与它们三维结构的差异有关。
  • Vinylogous imides. II. Ultraviolet spectra and the application of Woodward's rules
    作者:Daryl L. Ostercamp
    DOI:10.1021/jo00830a080
    日期:1970.5
  • Kava analogues as agents for treatment of periodontal diseases: Synthesis and initial biological evaluation
    作者:Bin Cai、James S. Panek、Salomon Amar
    DOI:10.1016/j.bmcl.2018.05.026
    日期:2018.9
    Six kava analogues of the structural type 3-oxocyclohex-1-en-1-yl benzoates (and corresponding benzamides) were synthesized and evaluated for their affect on periodontal deconstruction in collagen anti-body primed oral gavage model of periodontitis. The compounds were prepared through an acylation or amidation of the enolizable cyclic 1,3-diketone. We have learned that three of the analogues are responsible for the reduction of inflammatory cell counts within soft tissue. These novel kava-like molecules where the lactone is replaced by an alpha,beta-unsaturated ketone show promise in the prevention and treatment of inflammation and alveolar bone loss associated with periodontitis.
查看更多

同类化合物

(βS)-β-氨基-4-(4-羟基苯氧基)-3,5-二碘苯甲丙醇 (S)-(-)-7'-〔4(S)-(苄基)恶唑-2-基]-7-二(3,5-二-叔丁基苯基)膦基-2,2',3,3'-四氢-1,1-螺二氢茚 (S)-盐酸沙丁胺醇 (S)-3-(叔丁基)-4-(2,6-二甲氧基苯基)-2,3-二氢苯并[d][1,3]氧磷杂环戊二烯 (S)-2,2'-双[双(3,5-三氟甲基苯基)膦基]-4,4',6,6'-四甲氧基联苯 (S)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (R)富马酸托特罗定 (R)-(-)-盐酸尼古地平 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[((6-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-3-(叔丁基)-4-(2,6-二苯氧基苯基)-2,3-二氢苯并[d][1,3]氧杂磷杂环戊烯 (R)-2-[((二苯基膦基)甲基]吡咯烷 (N-(4-甲氧基苯基)-N-甲基-3-(1-哌啶基)丙-2-烯酰胺) (5-溴-2-羟基苯基)-4-氯苯甲酮 (5-溴-2-氯苯基)(4-羟基苯基)甲酮 (5-氧代-3-苯基-2,5-二氢-1,2,3,4-oxatriazol-3-鎓) (4S,5R)-4-甲基-5-苯基-1,2,3-氧代噻唑烷-2,2-二氧化物-3-羧酸叔丁酯 (4-溴苯基)-[2-氟-4-[6-[甲基(丙-2-烯基)氨基]己氧基]苯基]甲酮 (4-丁氧基苯甲基)三苯基溴化磷 (3aR,8aR)-(-)-4,4,8,8-四(3,5-二甲基苯基)四氢-2,2-二甲基-6-苯基-1,3-二氧戊环[4,5-e]二恶唑磷 (2Z)-3-[[(4-氯苯基)氨基]-2-氰基丙烯酸乙酯 (2S,3S,5S)-5-(叔丁氧基甲酰氨基)-2-(N-5-噻唑基-甲氧羰基)氨基-1,6-二苯基-3-羟基己烷 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-双(2,6-二甲氧基苯基)-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2S)-(-)-2-{[[[[3,5-双(氟代甲基)苯基]氨基]硫代甲基]氨基}-N-(二苯基甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[[((1R,2R)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2-硝基苯基)磷酸三酰胺 (2,6-二氯苯基)乙酰氯 (2,3-二甲氧基-5-甲基苯基)硼酸 (1S,2S,3S,5S)-5-叠氮基-3-(苯基甲氧基)-2-[(苯基甲氧基)甲基]环戊醇 (1-(4-氟苯基)环丙基)甲胺盐酸盐 (1-(3-溴苯基)环丁基)甲胺盐酸盐 (1-(2-氯苯基)环丁基)甲胺盐酸盐 (1-(2-氟苯基)环丙基)甲胺盐酸盐 (-)-去甲基西布曲明 龙胆酸钠 龙胆酸叔丁酯 龙胆酸 龙胆紫 龙胆紫 齐达帕胺 齐诺康唑 齐洛呋胺 齐墩果-12-烯[2,3-c][1,2,5]恶二唑-28-酸苯甲酯 齐培丙醇 齐咪苯 齐仑太尔 黑染料 黄酮,5-氨基-6-羟基-(5CI) 黄酮,6-氨基-3-羟基-(6CI) 黄蜡,合成物 黄草灵钾盐